Dagoberto V de Godoy1, Rossane F de Godoy. 1. Pulmonary Rehabilitation Program, Department of Pulmonology and Thoracic Surgery, Universidade de Caxias do Sul, Rio Grande do Sul, Brazil. dvggodoy@terra.com.br
Abstract
OBJECTIVE: To assess the effect of psychotherapy on the anxiety and depression levels of patients with chronic obstructive pulmonary disease (COPD). DESIGN: A blind, randomized, controlled trial. SETTING:Outpatient university pulmonary rehabilitation program in Brazil. PARTICIPANTS: Thirty patients with COPD (mean age, 60.33y; 22 men) attending a pulmonary rehabilitation program were randomized into 2 groups: experimental group (G1) and control group (G2). Both groups underwent a 12-week treatment program. INTERVENTIONS: Group 1 (n=14) participated in 24 sessions of physical exercise, 24 sessions of physiotherapy, 12 psychologic sessions, and 3 educational sessions. Group 2 did not participate in psychotherapy sessions. MAIN OUTCOME MEASURES: All patients were evaluated at baseline and at completion of the pulmonary rehabilitation program by using 3 instruments: the Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI), and 6-minute walk distance (6MWD). RESULTS: Both groups showed statistically significant improvements on the 6MWD (G1, P<.001; G2, P=.03). Only G1 had a significant reduction in anxiety and depression levels (G1: BAI, P<.001; BDI, P<.001; G2: BAI, P=.156; BDI, P=.142). Statistically significant differences existed between G1 and G2 for BAI (P<.001) and BDI (P=.02). CONCLUSIONS: Including psychotherapy in a pulmonary rehabilitation program for COPD reduced patients' anxiety and depression levels but did not modify 6MWD performance.
RCT Entities:
OBJECTIVE: To assess the effect of psychotherapy on the anxiety and depression levels of patients with chronic obstructive pulmonary disease (COPD). DESIGN: A blind, randomized, controlled trial. SETTING:Outpatient university pulmonary rehabilitation program in Brazil. PARTICIPANTS: Thirty patients with COPD (mean age, 60.33y; 22 men) attending a pulmonary rehabilitation program were randomized into 2 groups: experimental group (G1) and control group (G2). Both groups underwent a 12-week treatment program. INTERVENTIONS: Group 1 (n=14) participated in 24 sessions of physical exercise, 24 sessions of physiotherapy, 12 psychologic sessions, and 3 educational sessions. Group 2 did not participate in psychotherapy sessions. MAIN OUTCOME MEASURES: All patients were evaluated at baseline and at completion of the pulmonary rehabilitation program by using 3 instruments: the Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI), and 6-minute walk distance (6MWD). RESULTS: Both groups showed statistically significant improvements on the 6MWD (G1, P<.001; G2, P=.03). Only G1 had a significant reduction in anxiety and depression levels (G1: BAI, P<.001; BDI, P<.001; G2: BAI, P=.156; BDI, P=.142). Statistically significant differences existed between G1 and G2 for BAI (P<.001) and BDI (P=.02). CONCLUSIONS: Including psychotherapy in a pulmonary rehabilitation program for COPD reduced patients' anxiety and depression levels but did not modify 6MWD performance.
Authors: Nicholas D Giardino; Jeffrey L Curtis; Adin-Cristian Andrei; Vincent S Fan; Joshua O Benditt; Mark Lyubkin; Keith Naunheim; Gerard Criner; Barry Make; Robert A Wise; Susan K Murray; Alfred P Fishman; Frank C Sciurba; Israel Liberzon; Fernando J Martinez Journal: Respir Res Date: 2010-03-09
Authors: James A Blumenthal; Charles F Emery; Patrick J Smith; Francis J Keefe; Karen Welty-Wolf; Stephanie Mabe; Tereza Martinu; Julie J Johnson; Michael A Babyak; Virginia F O'Hayer; Philip T Diaz; Michael Durheim; Donald Baucom; Scott M Palmer Journal: Psychosom Med Date: 2014-10 Impact factor: 4.312
Authors: Zafar A Usmani; Kristin V Carson; Karen Heslop; Adrian J Esterman; Anthony De Soyza; Brian J Smith Journal: Cochrane Database Syst Rev Date: 2017-03-21
Authors: Janet Maurer; Venkata Rebbapragada; Soo Borson; Roger Goldstein; Mark E Kunik; Abebaw M Yohannes; Nicola A Hanania Journal: Chest Date: 2008-10 Impact factor: 9.410
Authors: James A Blumenthal; Francis J Keefe; Michael A Babyak; C Virginia Fenwick; Julie M Johnson; Kylie Stott; Rachel K Funk; Meredith J McAdams; Scott Palmer; Tereza Martinu; Don Baucom; Philip T Diaz; Charles F Emery Journal: Clin Trials Date: 2009-04 Impact factor: 2.486
Authors: Jacob N de Voogd; Johan B Wempe; Klaas Postema; Eric van Sonderen; Adelita V Ranchor; James C Coyne; Robbert Sanderman Journal: Ann Behav Med Date: 2009-10